As of 2025-05-15, the EV/EBITDA ratio of Genetic Signatures Ltd (GSS.AX) is -7.19. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GSS.AX's latest enterprise value is 95.37 mil AUD. GSS.AX's TTM EBITDA according to its financial statements is -13.26 mil AUD. Dividing these 2 quantities gives us the above GSS.AX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.4x - 15.1x | 12.2x |
| Forward P/E multiples | 11.5x - 18.9x | 13.2x |
| Fair Price | (0.49) - (0.71) | (0.57) |
| Upside | -183.0% - -219.1% | -195.2% |
| Date | EV/EBITDA |
| 2025-04-22 | -3.77 |
| 2025-04-17 | -4.02 |
| 2025-04-16 | -5.05 |
| 2025-04-15 | -4.37 |
| 2025-04-14 | -3.60 |
| 2025-04-11 | -3.42 |
| 2025-04-10 | -3.85 |
| 2025-04-09 | -3.85 |
| 2025-04-08 | -4.54 |
| 2025-04-07 | -4.54 |
| 2025-04-04 | -5.48 |
| 2025-04-01 | -5.14 |
| 2025-03-31 | -5.48 |
| 2025-03-28 | -5.57 |
| 2025-03-27 | -5.57 |
| 2025-03-26 | -6.68 |
| 2025-03-25 | -5.82 |
| 2025-03-21 | -5.74 |
| 2025-03-20 | -5.91 |
| 2025-03-19 | -6.25 |
| 2025-03-18 | -6.08 |
| 2025-03-17 | -5.99 |
| 2025-03-16 | -6.17 |
| 2025-03-14 | -6.08 |
| 2025-03-13 | -6.17 |
| 2025-03-12 | -6.17 |
| 2025-03-11 | -5.48 |
| 2025-03-10 | -5.74 |
| 2025-03-07 | -5.91 |
| 2025-03-06 | -6.08 |
| 2025-03-05 | -6.08 |
| 2025-03-04 | -6.51 |
| 2025-02-28 | -6.51 |
| 2025-02-27 | -6.51 |
| 2025-02-26 | -6.77 |
| 2025-02-25 | -5.65 |
| 2025-02-24 | -5.57 |
| 2025-02-21 | -5.48 |
| 2025-02-20 | -5.57 |
| 2025-02-19 | -5.14 |
| 2025-02-18 | -5.91 |
| 2025-02-17 | -5.91 |
| 2025-02-14 | -5.99 |
| 2025-02-13 | -6.08 |
| 2025-02-12 | -6.25 |
| 2025-02-11 | -6.25 |
| 2025-02-10 | -5.99 |
| 2025-02-07 | -6.68 |
| 2025-02-06 | -6.68 |
| 2025-02-05 | -6.85 |